Literature DB >> 9828745

Adverse neonatal effects of maternal labetalol treatment.

B N Crooks1, S A Deshpande, C Hall, M P Platt, D W Milligan.   

Abstract

Two infants with features of severe beta adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828745      PMCID: PMC1720843          DOI: 10.1136/fn.79.2.f150

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  8 in total

1.  Fetal death following labetalol administration in pre-eclampsia.

Authors:  K S Olsen; R Beier-Holgersen
Journal:  Acta Obstet Gynecol Scand       Date:  1992-02       Impact factor: 3.636

2.  Severe adverse effects of maternal labetalol in a premature infant.

Authors:  A Haraldsson; W Geven
Journal:  Acta Paediatr Scand       Date:  1989-11

3.  Neonatal adrenergic blockade following single dose maternal labetalol administration.

Authors:  J M Klarr; V Bhatt-Mehta; S M Donn
Journal:  Am J Perinatol       Date:  1994-03       Impact factor: 1.862

4.  Side effects of labetalol in newborn infants.

Authors:  D L Woods; A F Malan
Journal:  Br J Obstet Gynaecol       Date:  1983-09

5.  Half-life of maternal labetalol in a premature infant.

Authors:  A Haraldsson; W Geven
Journal:  Pharm Weekbl Sci       Date:  1989-12-15

6.  The effect of maternal labetalol on the newborn infant.

Authors:  M Macpherson; F Broughton Pipkin; N Rutter
Journal:  Br J Obstet Gynaecol       Date:  1986-06

7.  Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy.

Authors:  T P Stevens; R Guillet
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

8.  Effect of labetalol infusion on uterine and fetal hemodynamics and fetal cardiac function.

Authors:  P Jouppila; J Räsänen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1993-10       Impact factor: 2.435

  8 in total
  1 in total

Review 1.  Use of medication for cardiovascular disease during pregnancy.

Authors:  Petronella G Pieper
Journal:  Nat Rev Cardiol       Date:  2015-12       Impact factor: 32.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.